Cite

HARVARD Citation

    Montouchet, C. et al. (2013). Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspective. Journal of medical economics. pp. 907-916. [Online]. 
  
Back to record